Salesforce
CRM
MicroStrategy
MSTR
Coinbase
COIN
Adobe
ADBE
Oracle
ORCL
US Stock MarketDetailed Quotes
ADIL Adial Pharmaceuticals
- 1.1800
- +0.0700+6.31%
Trading Dec 4 15:39 ET
7.56MMarket Cap-356P/E (TTM)
1.3000High1.1300Low920.62KVolume1.1400Open1.1100Pre Close1.12MTurnover15.46%Turnover RatioLossP/E (Static)6.41MShares4.169952wk High1.29P/B7.03MFloat Cap0.765052wk Low--Dividend TTM5.95MShs Float236.0000Historical High--Div YieldTTM15.32%Amplitude0.7650Historical Low1.2120Avg Price1Lot Size
About Adial Pharmaceuticals Company
Adial Pharmaceuticals, Inc. engages in the development of therapeutics for the treatment or prevention of addiction and related disorders. It offers the AD04, a selective serotonin-3 antagonist. The company was founded by Bankole A. Johnson and William B. Stilley, III in November 2010 and is headquartered in Glen Allen, VA.
Company Profile
SymbolADIL
Company NameAdial Pharmaceuticals
Listing DateJul 27, 2018
Founded2010
CEOMr. Cary J Claiborne
MarketNASDAQ
Employees7
Fiscal Year Ends12-31
Address4870 Sadler Road,Suite 300
CityGlen Allen
ProvinceVirginia
CountryUnited States of America
Zip Code23060
Phone1-434-487-8196
Websitehttp://www.adialpharma.com
Company Executives
- Name
- Position
- Salary
- Cary J Claiborne
- Director, President and Chief Executive Officer
- 801.62K
- Vinay Shah
- Chief Financial Officer
- --
- Tony Goodman
- Director and Chief Operating Officer
- 261.93K
- Kevin Schuyler, C.F.A.,M.B.A.
- Chairman of the Board and Lead Independent Director
- 60.22K
- Robertson H. Gilliland, M.B.A.
- Independent Director
- 53.22K
- James W. Newman, Jr
- Independent Director
- 56.22K
- J. Kermit Anderson
- Independent Director
- 59.22K